insights_auto
Why is TMCI down 16.13%?
Dive Deeperchevron_right
TMCI:NASDAQ
Treace Medical Concepts, Inc
$4.42
arrow_downward
-16.13%(-0.85) 1D
$4.58
arrow_upward
+3.62% (+0.16)bedtimeAfter hours
Closed: Nov 16, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TMCI...
Open
$5.23
High
$5.36
Low
$4.37
Mkt. cap
289.77M
Avg. vol.
298.58K
Volume
0.00
52-wk high
$5.43
52-wk low
$1.17
EPS
-$0.86
Beta
1.59
Shares outstanding
65.56M
No. of employees
450
Open
$5.23
High
$5.36
Low
$4.37
Mkt. cap
289.77M
Avg. vol.
298.58K
Volume
0.00
52-wk high
$5.43
52-wk low
$1.17
EPS
-$0.86
Beta
1.59
Shares outstanding
65.56M
No. of employees
450
News stories
From web sources and news partners
Benzinga
·
52 minutes ago
Stock Market: Will S&P 500 Open Up or Down Today?
The Motley Fool
·
15 hours ago
Is an Equal-Weight S&P 500 Fund Safer Right Now Than the One You Own?
ChartMill
·
13 hours ago
Today's S&P 500 Top Movers: Tyson Foods Leads Gainers, Lumentum Leads Decliners
Traders Union
·
8 hours ago
Michael A. Gayed: S&P 500 fell 19.35% and high yield dropped 5.9% in Q4 2018 selloff
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc